Michael T. Cullen - Oct 4, 2022 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
PBLA
Transactions as of
Oct 4, 2022
Transactions value $
$0
Form type
4
Date filed
10/6/2022, 06:14 PM
Previous filing
May 27, 2021
Next filing
Mar 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBLA Common Stock Purchase +165K +80.65% 370K Oct 4, 2022 By Cullen Living Trust Dated April 23, 2009 F1
holding PBLA Common Stock 217K Oct 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Warrants (right to buy) Purchase $0 +247K $0.00 247K Oct 4, 2022 Common Stock 247K $0.30 By Cullen Living Trust Dated April 23, 2009
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.